The Third Xiangya Hospital of Central South University

🇨🇳China

Country: 🇨🇳China

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.xy3yy.com

Clinical Trials

In-hospital Neutron Irradiator (IHNI)-Based Boron Neutron Capture Therapy (BNCT) in the Treatment of Malignant Melanoma

Phase 1

Conditions: Melanoma
Boron Neutron Capture Therapy

Interventions: Radiation: Boronophenylalanine and IHNI-based BNCT

First Posted Date: 2016-05-03

Last Posted Date: 2016-06-07

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 30

Registration Number: NCT02759536

Locations: 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Domestic Surgical Robot Clinical Study

Not Applicable

Conditions: Rectal Cancer
Cholecystolithiasis
Appendicitis
Gastric Bypass
Gastric Ulcer With Perforation But Without Obstruction
Colon Cancer
Sleeve Gastrectomy
Gastric Cancer

Interventions: Procedure: Micro Hand S robotic surgery
Procedure: laparoscopic surgery
Procedure: da Vinci robotic surgery

First Posted Date: 2016-04-27

Last Posted Date: 2021-04-01

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 200

Registration Number: NCT02752698

Locations: 🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Study of Statin for Reduction of Postoperative Paroxysmal Atrial Fibrillation

Phase 4

Conditions: Paroxysmal Atrial Fibrillation

Interventions: Drug: rosuvastatin

First Posted Date: 2015-07-20

Last Posted Date: 2015-07-21

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 346

Registration Number: NCT02502110

Diagnostic Values of Lung Ultrasound for Perioperative Atelectasis

Completed

Conditions: Postoperative Pulmonary Atelectasis

First Posted Date: 2015-02-04

Last Posted Date: 2015-04-21

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 46

Registration Number: NCT02355405

Locations: 🇨🇳
Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China

Genotype-guided Warfarin Individualized Treatment

Not Applicable

Completed

Conditions: Atrial Fibrillation
Deep Venous Thrombosis

Interventions: Behavioral: Genotype-guided dosing algorithm for warfarin
Behavioral: Standard initiation dose for warfarin

First Posted Date: 2014-08-07

Last Posted Date: 2017-11-06

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 660

Registration Number: NCT02211326

Locations: 🇨🇳
The Third Hospital of Changsha, Changsha, Hunan, China
🇨🇳
The Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳
The First Affiliated Hospital of Nanhua university, Hengyang, Hunan, China

and more 12 locations

Testing of HIV Protease Inhibitors to Suppress Inflammation and Improve Cardio Pulmonary Hemodynamics in Subjects With Pulmonary Arterial Hypertension

Early Phase 1

Conditions: Pulmonary Arterial Hypertension

Interventions: Drug: saquinavir and ritonavir

First Posted Date: 2013-12-30

Last Posted Date: 2014-09-08

Lead Sponsor: The Third Xiangya Hospital of Central South University

Target Recruit Count: 20

Registration Number: NCT02023450

Locations: 🇨🇳
Xiangya hospital, Changsha, Hunan, China

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy